Our results collectively demonstrate a novel role of SOX9 and the regulation of SOX9/AMH by AR signaling in the pathogenesis of SCOS, potentially offering a new direction in the search for androgen therapies in partial SCOS patients who have suffered repeated sperm retrieval failure history. This evidence concerns the gene AR and small cell osteogenic sarcoma.